Trace Amines and Neurological Disorders 2016
DOI: 10.1016/b978-0-12-803603-7.00018-5
|View full text |Cite
|
Sign up to set email alerts
|

Trace Amines in Neuropsychiatric Disorders

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
3
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 106 publications
0
3
0
Order By: Relevance
“…Tyramine binding to G-protein-coupled receptors in the synaptic cleft reduces the activity of serotonergic and dopaminergic receptors [107], and imbalance in tyramine levels has been reported to be associated with Parkinson's disease, depression, schizophrenia, migraine, and elevated blood pressure [108][109][110][111]. Our results suggest that it is one of the reasons for the progression of pathology in AD.…”
Section: Discussionmentioning
confidence: 53%
“…Tyramine binding to G-protein-coupled receptors in the synaptic cleft reduces the activity of serotonergic and dopaminergic receptors [107], and imbalance in tyramine levels has been reported to be associated with Parkinson's disease, depression, schizophrenia, migraine, and elevated blood pressure [108][109][110][111]. Our results suggest that it is one of the reasons for the progression of pathology in AD.…”
Section: Discussionmentioning
confidence: 53%
“…TAAR1 has been found to heterodimerize with the dopamine receptor 2, which is thought to silence glycogen synthase kinase 3 beta (GSK3β) implicated in various mental disorders [3]. Imbalances in levels of tyramine have been reported to be associated with Parkinson's disease, depression, schizophrenia, migraines and increased blood pressure [1,[4][5][6]. In mammalian cells, tyramine has been found to be toxic [7], to cause oxidative damage [4] and to have effects on mitochondrial respiratory function [8].…”
Section: Introductionmentioning
confidence: 99%
“…2 Endogenous arylethylamines including dopamine and serotonin underlie the neurochemistry of emotion, memory, and addiction. [3][4][5] Drugs with incorporated arylethylamine connectivity have been developed to treat heart disease 6 and cancer 7 (Scheme 1A) among numerous other indications. The arene and ethylene portions bear several potential sites of substitution that can act as synthetic handles to tune the molecule's metabolic and pharmacokinetic profile.…”
mentioning
confidence: 99%